Verona Pharma PLC ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $103,138 | $76,256 | $36,655 | $5,624 |
Gross Profit | 98,382 | 72,849 | 34,616 | 5,081 |
EBITDA | 18,997 | -6,091 | -14,980 | -34,526 |
EBIT | 18,704 | -6,387 | -15,239 | -34,795 |
Net Income | 11,921 | -16,319 | -33,827 | -42,962 |
Net Change In Cash | 103,138 | 76,256 | 36,655 | 5,624 |
Free Cash Flow | 30,561 | -11,561 | -29,371 | -62,655 |
Cash | 438,016 | 401,415 | 399,757 | 336,040 |
Basic Shares | 90,902 | 84,925 | 81,538 | 81,493 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $42,279 | $458 | $458 | $40,000 |
Gross Profit | 39,697 | -679 | 112 | 40,000 |
EBITDA | -142,188 | -52,467 | -67,291 | -42,189 |
EBIT | -143,247 | -53,147 | -67,927 | -42,818 |
Net Income | -173,418 | -54,369 | -68,701 | -55,569 |
Net Change In Cash | 42,279 | 458 | 458 | 40,000 |
Free Cash Flow | -122,783 | -50,222 | -59,891 | -33,266 |
Cash | 399,757 | 271,772 | 227,827 | 148,380 |
Basic Shares | 81,538 | 79,267 | 66,133 | 59,148 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.005 |
2025-03-31 | -$0.02 |
2024-12-31 | -$0.05 |
